Article Details
Retrieved on: 2021-02-13 03:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Last week, the country's drug safety agency approved pharmaceutical giant Celltrion Inc.'s CT-P59, an anti-COVID-19 monoclonal antibody treatment, ...
Article found on: en.yna.co.kr
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here